Upstate Active Clinical Trials
Study Title:A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants with Moderately to Severely Active Lupus Erythematosus. SL0043
Upstate Institutional Review Board (IRB) Number:1687158
Patient Age Group:Adults
Principal Investigator:Andras Perl, MD, PhD
Who can I contact for more information?
Name: Joanne M Chilton, CCRP